4//SEC Filing
Murphy Nicole 4
Accession 0001127602-25-004461
CIK 0000875045other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 5:47 PM ET
Size
8.3 KB
Accession
0001127602-25-004461
Insider Transaction Report
Form 4
BIOGEN INC.BIIB
Murphy Nicole
Head of Pharm Ops and Tech
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-02-10−2,272→ 0 totalExercise: $0.00Exp: 2025-02-10→ Common Stock (2,272 underlying) - Exercise/Conversion
Common Stock
2025-02-10+2,272→ 14,725.374 total - Tax Payment
Common Stock
2025-02-10$142.54/sh−670$95,502→ 14,055.374 total
Footnotes (1)
- [F1]The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.
Documents
Issuer
BIOGEN INC.
CIK 0000875045
Entity typeother
Related Parties
1- filerCIK 0001910644
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 5:47 PM ET
- Size
- 8.3 KB